Immunovant Inc.

14.42
-1.36 (-8.62%)
At close: Apr 04, 2025, 12:42 PM

Immunovant Balance Sheet Statement

Financials in USD. Fiscal year is April - March.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018
Period Ending Mar 31, 2024 Mar 31, 2023 Mar 31, 2022 Mar 31, 2021 Mar 31, 2020 Mar 31, 2019 Mar 31, 2018
635.37M 376.53M 493.82M 400.15M 100.57M 325K n/a
n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a 246K 79.95K n/a
5.5M 885K 12.86M 1.14M 3.04M n/a n/a
n/a -0.00 -0.00 0.00 n/a n/a n/a
24.9M n/a n/a n/a n/a n/a n/a
665.77M 404.33M 512.93M 409.01M 109.08M 325K 113.17K
595K 1.5M 2.63M 3.48M 65K 54.00 n/a
n/a n/a n/a n/a n/a n/a n/a
595K 1.5M 2.63M 3.48M 311K 80K n/a
666.37M 405.84M 515.56M 412.49M 109.39M 405K 113.17K
7.16M 1.35M 18.63M 2.43M 1.19M 206.00 1.14M
n/a n/a n/a n/a -3.19M -206 n/a
n/a n/a n/a 1.18M 3.19M 300K n/a
14.74M 350K 171K 10.84M n/a -206 n/a
48.61M 43.3M 44.52M 18.77M 15.32M 380.45K 1.61M
n/a n/a n/a n/a n/a n/a n/a
-347K n/a n/a n/a n/a n/a n/a
n/a 47K 1.22M 2.24M 14.13M 300K n/a
48.61M 43.34M 45.74M 21.01M 15.32M 380.45K 1.61M
138K 1.22M 2.36M 3.42M 3.19M 300K n/a
14K 13K 12K 10K 5K 288.00 n/a
-825.68M -566.35M -355.39M -198.66M -91.23M -448 n/a
1.91M 852K 404K -298K -16K 343K -1.5M
617.76M 362.49M 469.82M 391.48M 94.07M 24.55K -1.5M
n/a n/a n/a n/a n/a n/a n/a